Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups

Cell Reports(2020)10.1016/j.celrep.2020.107920Source: DataRank Database

Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups is a research paper published in Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.51)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

David Lowe ORCID,Todd G. Smith,Yong Yang ORCID,Christina L. Hutson ORCID,Christoph Wirblich ORCID

Live enrichment

PubMed:32697993 PMC:PMC7373069 OpenAlex:https://openalex.org/W3044726013

Centers for Disease Control and Prevention

Grant: WO2018231974A1

National Institutes of Health

Grant: R21 AI128175

NIAID NIH HHS

Grant: R01 AI149795

NIAID NIH HHS

Grant: R01 AI123272

National Institutes of Health

FWCI

1.51

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.celrep.2020.107920

publisherhttps://doi.org/10.1016/j.celrep.2020.107920

publisherhttps://api.elsevier.com/content/article/PII:S2211124720309013?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124720309013?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32697993

Fields of Study

Rabies epidemiology and controlStreptococcal Infections and TreatmentsMicrobial infections and disease research

MeSH Terms

Administration, IntranasalAntibodies, ViralGlycoproteinsInjections, IntramuscularPhylogenyRabies VaccinesRecombinant ProteinsViral VaccinesVirus ReplicationLyssavirusImmunity, HumoralAntibodies, Neutralizing

Keywords

LyssavirusVirologyRabiesRabies virusBiologyRecombinant DNARhabdoviridaeGeneticsGeneProtein engineeringVaccineStructural modelingProphylaxisRhabdovirusesLyssavirusesGla-se

Sustainable Development Goals

SDG 0: Good health and well-being

Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups

FAIR Checklist

Authors (8)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)